Biotech and Money is a member’s only community of senior level executives from the global biotechnology industry.

The community provides an exclusive nexus between drug developers, investors, financiers and legal and professional advisors.

It is a network that enables knowledge sharing, connections, partnerships and deal making between its exclusive membership, 365 days a year.

We provide our members with a platform to identify capital raising and funding sources, investment opportunities and potential partnerships, licensing and M&A targets and conduct business development. It’s where innovation meets investment.

Biotech and Money is a global community that secures members from across Europe, North America and Asia, plus the fastest growing ‘Pharmerging’ markets.


  • C-suite executives from small and mid- cap biotech companies with active pre- clinical and clinical research pipelines.
  • Business Development and Licensing representatives and Therapeutic Heads from the industry’s leading large-cap Biotech and Pharmaceutical manufacturers.
  • Partners and Managing Partners from Pharmaceutical venture arms and venture capital firms who are actively investing in biotechnology.
  • Partners from the top percentile of global law firms, management consultants and investment banks with Life science and biotechnology practices.
  • Applying members must meet strict criteria to be considered for annual membership. Biotech and money does not accept membership applications from vendors or suppliers. ​​